Stockholm, Sweden June 27th, 2007 -- The Swedish pharmaceutical company Moberg Derma AB, today announced that it has successfully completed the financing of SEK 27,7 million. TheBaltic Sea Foundation (Östersjöstiftelsen) was the lead investor and was joined by other institutional and private investors, as well as membersof management.
